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Abstract
Background:  Myocardial perfusion imaging (MPI), using single photon emission computed
tomography (SPECT) is a validated method for detecting coronary artery disease. Transthoracic
Doppler echocardiography (TTDE) of flow at rest and during adenosine provocation has previously
been evaluated in selected patient groups. We therefore wanted to compare the diagnostic ability
of TTDE in the left anterior descending coronary artery (LAD) to that of MPI in an unselected
population of patients with chest pain referred for MPI. Our hypothesis was that TTDE with high
accuracy would identify healthy individuals and exclude them from the need for further studies,
enabling invasive investigations to be reserved for patients with a high probability of disease.
Methods: Sixty-nine patients, 44 men and 25 women, age 61 ± 10 years (range 35–82), with a
clinical suspicion of stress induced myocardial ischemia, were investigated. TTDE was performed
at rest and during adenosine stress for myocardial scintigraphy.
Results:  We found that coronary flow velocity reserve (CFVR) determined from diastolic
measurements separated normal from abnormal MPI findings with statistical significance. TTDE
identified coronary artery disease, defined from MPI, as reversible ischemia and/or permanent
defect, with a sensitivity of 60% and a specificity of 79%. The positive predictive value was 43% and
the negative predictive value was 88%. There was an overlap between groups which could be due
to abnormal endothelial function in patients with normal myocardial perfusion having either
hypertension or diabetes.
Conclusion: TTDE is an attractive non-invasive method to evaluate chest pain without the use of
isotopes, but the diagnostic power is strongly dependent on the population investigated. Even in
our heterogeneous clinical cardiac population, we found that CFVR>2 in the LAD excluded
significant coronary artery disease detected by MPI.
Background
Coronary artery disease (CAD) is the most common cause
of death in the western world, despite advances in medi-
cal, interventional and surgical treatments. The diagnosis
of coronary disease is often based on patient symptoms
and an exercise test. However, the sensitivity for the detec-
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tion of ischemia using exercise in combination with elec-
trocardiography is low, in the range of 60% [1].
Myocardial perfusion imaging (MPI) in combination with
stress increases sensitivity to about 85% without compro-
mising specificity [2]. If verification bias (where the selec-
tion process results in a higher prevalence of disease than
in a clinical population) is taken into account, exercise
stress testing as well as other non-invasive testing could
have a sensitivity as low as 40% and specificity of 80%
[3,4]. The drawback of scintigraphy is exposure to radia-
tion. Echocardiography is inexpensive, widely available,
non-invasive and, in combination with Doppler, flow
velocity in the epicardial coronary vessels can be interro-
gated [5]. The method is demanding for the operator but
could become a widely available and inexpensive diag-
nostic modality, especially if combined with pharmaco-
logical stress [6-8].
Gould et al have shown that resting coronary blood flow
does not decrease until coronary artery diameter is
reduced by 85%. The coronary flow reserve, however,
begins to decrease already with a 30–45% reduction of the
arterial diameter [9,10]. In healthy coronary arteries, ade-
nosine provokes an increase in coronary flow 3–6 times
the resting value [11]. Coronary flow velocity reserve
(CFVR) is defined as the ratio between coronary flow
velocities during maximal hyperaemia and at rest. CFVR
has been used as an index of normality in studies of path-
ological processes such as coronary obstructive disease
and endothelial dysfunction [12,13]. Previous studies
[14-18] have produced encouraging results for the diagno-
sis of significant coronary stenoses. Since the method so
far has been applied mainly in selected patient popula-
tions, we wanted to study if it could be applied in a rou-
tine clinical setting, where patients with coronary artery
disease as well as with various cardiovascular conditions
that are associated with endothelial dysfunction present
with chest pain. Thus, in contrast to most previous studies
[19-21], patients with previous revascularization, surgical
valve procedures, non-sinus rhythm, artificial pacemaker,
bundle branch block, hypertension, cardiomyopathy and
diabetes mellitus were also included. In this clinical pop-
ulation we set forth to assess transthoracic coronary Dop-
pler echocardiography (TTDE) compared to our standard
MPI method.
Methods
Study population
Sixty-nine patients (44 men, 25 women; mean age 61 ± 10
years) were enrolled between November 2004 and Octo-
ber 2005. They were all referred for myocardial perfusion
imaging because of suspected or known CAD. Eighteen
had a history of a previous myocardial infarction and 14
were revascularised (9 with PCI and 5 with CABG). One
patient had an aortic valve prosthesis. Sixty-six patients
were in sinus rhythm, 2 in atrial fibrillation and one had
a pacemaker. Twenty-three patients had a normal electro-
cardiogram (ECG). Twenty-two patients had anti-hyper-
tensive treatment and 11 were diabetics. Forty-six patients
were on betablockers, 10 on calcium inhibitors and 16 on
ACE inhibitors. No changes in medication were made
prior to the study. Exclusion criteria were acute myocar-
dial infarction, unstable angina, 2nd degree AV-block or
higher, obstructive pulmonary disease or treatment with
dipyridamole as well as theophylline preparations. The
subjects were instructed to abstain from xanthine-contain-
ing food and drinks (chocolate, cola, coffee and tea) for at
least 24 hours before the study.
The study was approved by the Regional Ethics Committe
at Linköping University. All subjects gave informed con-
sent.
Adenosine infusion protocol
Adenosine is a potent vasodilatator producing maximal
coronary vasodilatation within 40–50 seconds. The
plasma half-life is less than 10 seconds and side-effects
(mainly hyperpnea and flush) and hyperaemia thus sub-
side quickly after termination of infusion. Adenosine was
administered intravenously (0.140 mg/kg/min) for 5
minutes. A 12-lead ECG was continuously recorded
before, during and up to 5 minutes after the adenosine
infusion. Blood pressure was determined at rest and at
1–2 minutes intervals during the infusion. Preset criteria
for reducing or stopping the infusion were acute bron-
chospasm, advanced AV block, decrease in systolic blood
pressure > 20 mmHg or patient refusal.
Transthoracic Doppler echocardiography
Echocardiographic examinations were performed with a
Sequoia C256 or 512 (Siemens Acuson, Mountain View,
California) using a broadband transducer (3V2c and 4V1c
respectively). For colour Doppler (CD) flow mapping, the
velocity range was set at 12 to 20 cm/s. The colour gain
was adjusted to provide optimal images with minimal
"bleeding" of colour onto tissue, fig 1. Coronary flow
velocity was measured with pulsed wave Doppler at 3.5
MHz using CD as a guide. Gate size was set at 4–5 mm.
Angle correction was performed if the angle between the
CD flow and the Doppler beam exceeded 20 degrees and
was maintained during rest and stress studies. The spectral
trace of the coronary flow was characteristically biphasic
with a dominating diastolic component. Stop frames and
clips were digitally recorded for off-line analysis, figs 2
and 3.
The patients were examined in the left lateral position.
The aim was to record flow in the most distal part of the
left anterior descending artery (LAD). To image the distal
LAD, the transducer was positioned either at the cardiacCardiovascular Ultrasound 2008, 6:12 http://www.cardiovascularultrasound.com/content/6/1/12
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apex or one intercostal space above and focused on the
proximal field. The transducer was rotated and tilted until
the distal coronary segment could be visualized by CD at
the epicardial part of the anterior wall. Alternatively, a
short axis view of the left ventricular apex and anterior
groove was interrogated with CD. When diastolic CD
blood flow was detected, the transducer was slowly
rotated clockwise to obtain the best long axis view of the
LAD.
If no CD blood-flow from the LAD was visualized in the
baseline condition before the infusion, a new resting
recording was made at least 5 minutes after the infusion
was stopped. No contrast agent was used.
Stop frames of the spectral Doppler signal were repeatedly
stored during the investigation. Each study was analysed
off-line. Measurements were performed by tracing the
contour of the Doppler signal on the ultrasound monitor.
Signals with a well defined outline were analysed and
diastolic peak velocities, mean diastolic velocities and
diastolic velocity time integrals were measured at baseline
and peak hyperaemic conditions. Due to systolic move-
ments of the heart, the systo-diastolic averaged peak
velocity and velocity time integral were not always deter-
mined. The measurements were, if possible averaged over
three consecutive heart beats. Coronary flow reserve was
calculated as the ratio of peak hyperaemic and basal mean
diastolic velocities without knowledge of the results of the
SPECT myocardial perfusion imaging.
Myocardial perfusion imaging
Gated myocardial SPECT was performed using a two-day
stress/rest protocol. Adenosine was infused continuously
for 5 minutes. At 3 minutes into the infusion, Tc-99m
tetrofosmin (5.7 MBq/kg bodyweight) was injected.
Colour Doppler recording of LAD flow at rest Figure 1
Colour Doppler recording of LAD flow at rest.Cardiovascular Ultrasound 2008, 6:12 http://www.cardiovascularultrasound.com/content/6/1/12
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Supine gated SPECT images were acquired 45–60 minutes
later. Rest images were obtained 3–5 days later using 8.6
MBq 99mTc- tetrofosmin/kg bodyweight with acquisition
starting 45–60 minutes after the injection. The patients
were offered cold water to drink before acquisition in
order to diminish bowel artifacts.
The acquisitions were made on a dual-detector gamma
camera (ECAM Siemens Medical Systems Inc) with a low
energy high resolution collimator using 64 projections
over 180° (right anterior oblique 45° to left posterior
oblique 45°), 30 s per projection. A 19% window was
asymmetrically placed (129–155 keV) on the 140 keV
peak, asymmetry 2%. The gated and un-gated data were
separately reconstructed on a Hermes Medical Solutions
(Stockholm, Sweden) workstation. Prefiltering with a But-
terworth filter (cut off 0.8/cm, order 10) was applied fol-
lowed by filtered back projection. No scatter or
attenuation correction was applied. The reconstructed
transaxial data were realigned along the heart axis. The
short axis slices were then processed with the automatic
software packages QPS and QGS (Cedars-Sinai Medical
Center, Los Angeles, CA, USA).
The images were interpreted separately by 2 experienced
physicians without knowledge of the outcome of the
TTDE. Each observer classified the studies as normal,
probably normal, equivocal, probably abnormal and
abnormal. In case of an equivocal result, the gated study
was evaluated in cine mode, making it possible to reclas-
sify the study as either probably normal or probably
abnormal. Finally, the normal and probably normal stud-
ies were grouped together as were the probably abnormal
and the abnormal studies. The perfusion defects were also
Spectral Doppler recording of LAD flow at rest Figure 2
Spectral Doppler recording of LAD flow at rest.Cardiovascular Ultrasound 2008, 6:12 http://www.cardiovascularultrasound.com/content/6/1/12
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assigned to LAD, LCX and/or RCA territories. In three
cases there was disagreement between the two observers
and consensus was negotiated.
The "Summed Stress Score" as a measure of perfusion
abnormalities was also quantitatively analysed with the
software package commonly used in our clinic (QPS
Cedars Sinai, Los Angeles, CA, USA).
Statistical analysis
Descriptive statistics were used in combination with Stu-
dents' t-test, paired or un-paired, when appropriate as well
as Pearson Chi-square (SPSS Inc, Chicago, Illinois, USA).
A p-value of < 0.05 was considered significant.
Results
The clinical characteristics of the patient population are
summarized in table 1.
The outcome in groups where CFVR was successfully cal-
culated is summarized in table 2. TTDE identified coro-
nary artery disease, defined from MPI as reversible
ischemia and/or permanent defect, with a sensitivity of
60% and a specificity of 79%. The positive predictive
value was calculated to 43% and the negative predictive
value to 88%. Due to few patients with abnormal SPECT,
the pre-test-probability was only 21%. The mean coeffi-
cient of variation for the calculation of CFVR, obtained by
one operator (intraobserver variability), was 3.9%.
Fig 4 shows the spread in individual CFVR values for
patients with normal or abnormal MPI. The mean value
for patients with normal MPI was 2.51 and for abnormal
MPI 2.22, p = 0.36. The four patients shown in figure 4
having abnormal SPECT but CFVR>2 had spectral Dop-
pler signals of good quality. Two of these patients had per-
fusion defects in territories of the right coronary artery
Spectral Doppler recording of LAD flow during stress Figure 3
Spectral Doppler recording of LAD flow during stress.Cardiovascular Ultrasound 2008, 6:12 http://www.cardiovascularultrasound.com/content/6/1/12
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(RCA) but not the LAD where CFVR was measured. In the
third patient, the Doppler signal drifted into a stent in the
LAD during stress giving a higher stress velocity and there-
fore a falsely high CFVR. The fourth patient had a stenosis
in the anastomosis between the left internal mammary
artery (LIMA) and the LAD causing an overestimation of
CFVR.
The eight patients with normal SPECT but reduced CFVR
all had risk factors for endothelial dysfunction.
No serious adverse reactions occurred during adenosine
infusion. In 5 patients, the hyperpnea and discomfort
caused patient movements precluding the Doppler
recording but the adenosine-infusion was not disrupted.
TTDE without contrast visualized a distal segment of the
LAD in 52 of the 69 patients but CFVR could be calculated
only in 48 patients (success rate 70%).
No significant differences were found regarding age, gen-
der, BMI, systolic blood pressure, known CAD (previous
AMI, PCI and/or CABG), normal/abnormal myocardial
SPECT between the group where CFVR was successfully
calculated and the group where CFVR was not obtained.
Also, the groups did not differ with reference to ischemic
burden according to the "Summed Stress Score" calcu-
lated with QPS, (4.8 ± 5.4 and 6.7 ± 7.0 respectively, p =
0.27).
Discussion
A CFVR >2 identified patients without SPECT signs of
fixed or reversible coronary artery disease with a moder-
ately high specificity (79%).
Our study population contained patients with previous
revascularization, hypertension, cardiomyopathy and dia-
betes mellitus. These conditions are associated with
reduced endothelial function that might obscure the
detection of coronary artery disease [22], thus explaining
the low sensitivity (60%). In addition, patients with
LBBB/pacemaker/non-sinus rhythm and previous valve
procedures were also included. Most previous validation
studies of TTDE have not had this approach to patient
selection [19-21]. The low pre-test-probability in our
study (21% according to MPI) also influenced the sensi-
tivity of transthoracic coronary Doppler.
Since MPI is the most frequently used non-invasive
method for ruling out significant coronary artery disease
and its high diagnostic accuracy is well documented
[23,24], we chose to use it as our reference method,
despite its rather low specificity [25]. A drawback with
scintigraphy is the radiation exposure, about 10 mSv in
our clinic. Invasive coronary angiography was not clini-
cally indicated in our patient population and could there-
fore not be used as reference.
Which conditions may complicate the use of TTDE? Ade-
nosine, a strong dilator of the coronary microcirculation,
is considered to have little effect on the epicardial arteries
[26]. If the epicardial vessel diameter is unchanged during
the infusion of adenosine, velocity can be used as a surro-
gate for flow, mainly reflecting the condition of the micro-
vascular circulation. However, Kiviniemi et al have shown
that the epicardial coronary arteries increase in diameter
up to 31% during adenosine infusion [27]. The measure-
ment of flow velocity increase can therefore underesti-
mate the increase in volume flow and thereby the increase
in coronary flow reserve.
Table 1: Clinical characteristics. Demographic data and clinical characteristics. When appropriate, mean values ± SD are given.
Total Successful CFVR Unsuccessful CFVR Sign.
Number of patients 69 48 21
Age (year) 61 ± 10 61 ± 11 60 ± 10 ns
Gender (Male/Female) 44/25 34/14 10/11 ns
BMI 27 ± 4 27 ± 4 28 ± 4 ns
BPsys (mmHg) 133 ± 19 134 ± 19 133 ± 22 ns
BPdia (mmHg) 76 ± 9 76+13 76 ± 6 ns
Diabetics (number) 11 9 2 ns
CAD (number) 22 16 6 ns
Normal EKG (number) 23 18 5 ns
Table 2: Comparison between CFVR and MPI. CFVR and result 
of MPI in groups where CFVR was successfully calculated (p = 
0.043, Chi-square)
CFVR/Scint Normal MPI Abnormal MPI Total
>2 30 4 34
≤28 6 1 4
Total 38 10 48Cardiovascular Ultrasound 2008, 6:12 http://www.cardiovascularultrasound.com/content/6/1/12
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Withdrawal of vasoactive medication was not required in
our clinical routine. However, betablockers have been
shown to increase CFVR while vasodilators have caused
an underestimation of CFVR by reducing the maximal
vasodilator response to adenosine[28]. It has been sug-
gested that anti-anginal medication should be withheld
48 hrs prior to vasodilator stress [29].
In previous studies, adenosine or dipyridamole were used
as vasodilators [30]. We chose adenosine because of our
familiarity with its properties. The short half life enabled
the recording of resting values after the termination of
adenosine infusion, when necessary. However, the hyper-
pnoea associated with the vasodilating effect of adenosine
prevented us from performing wall motion analysis and it
caused such discomfort that calculation of CFVR was
impossible in some patients.
We have refrained from using external ultrasound contrast
due to signal scattering in colour as well as in spectral
Doppler recordings. Recent publications have shown that
the use of ultrasound contrast markedly improves the
measurement of coronary flow velocity [31-33]. However,
in view of recent warnings issued by FDA, the use of echo
contrast should be considered with caution [34]. Better
ultrasound hardware, e.g. more channels, increased col-
our Doppler sensitivity and better focused ultrasound
probes could further improve future results.
This study was performed by one experienced ultrasound
operator, who in preparation for this study, devoted con-
siderable time to master the skills of coronary scanning.
Still, the success rate was low, 70%, partly due to difficult
scanning conditions in overweight patients and partly due
to the discomfort induced by adenosine itself. Thus, the
selection of patients seems as important as training in
improving the success rate. In this study, we limited TTDE
scanning to the LAD and the result was compared with
MPI in the LAD territory. However, other authors have
shown the applicability of scanning all three coronary ves-
sels [35].
Conclusion
In conclusion, based on our results, we suggest that
CFVR>2 in the LAD will exclude significant coronary
artery disease in a clinical setting. A low CFVR is more dif-
Individual results of CVFR plotted against result from MPI Figure 4
Individual results of CVFR plotted against result from MPI. Heavy line indicates the limit for CFVR at 2.
 
 
Coronary Flow Velocity Reserve 
Normal MPI Abnormal MPICardiovascular Ultrasound 2008, 6:12 http://www.cardiovascularultrasound.com/content/6/1/12
Page 8 of 9
(page number not for citation purposes)
ficult to interpret since multiple cardiovascular and meta-
bolic risk factors as well as epicardial vessel disease or
microvascular dysfunction might be responsible. This
complicates the use of TTDE as a method for detecting
coronary disease in individual patients with a heterogene-
ous clinical background. However, because of its non-
invasive nature and absence of radiation, the method
seems to be well suited for repeated investigations of
CFVR in a variety of pathophysiological conditions, such
as detecting changes in endothelial function after intensi-
fied treatment in patients with cardiovascular risk factors.
These results may stimulate future clinical studies on the
use of TTDE in clinical practice.
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